The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke

Clinica Chimica Acta

Volumn 396, Issue 1-2, 2008, Pages 7-9

  Shi, Congning ^a   Kang, Xixiong ^a   Wang, Yajie ^a   Zhou, Yali ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chinese young adults; eNOS; Genetics; Ischemic stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE 4A; ENDOTHELIAL NITRIC OXIDE SYNTHASE 4B; HOMOCYSTEINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMOSTASIS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CHINA; FACTOR V; FEMALE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS; STROKE;

EID: 50249152336     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.06.009     Document Type: Article

References (30)

1. Hart R.G., and Miller V.T. Cerebral infarction in young adults: a practical approach. Stroke 14 (1983) 110-114
2. Adams H.P., Butler M.J., Biller J., and Toffol G.J. Nonhemorrhagic cerebral infarction in young adults. Arch Neurol 43 (1986) 793-796
3. Bertina R.M., Koeleman B.P.C., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
4. Adriano de P.S., Ribeiro D.D., das Gracas Carvaho M., Cardoso J., Sant'Ana Dusse L.M., and Fernandes A.P. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinolysis 17 (2006) 271-275
5. Ridker P.M., Hennekens C.H., Lindpainter K., Stampfer M.J., Eisenberg P.R., and Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 332 (1995) 912-917
6. Longstreth Jr. W.T., Rosendaal F.R., Siscovick D.S., et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 29 (1998) 577-580
7. Margaglione M., D'Andrea G., Giuliani N., et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 19 (1999) 1751-1756
8. Voetsch B., Damasceno B.P., Camargo E.C.S., et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 83 (2000) 229-233
9. Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., and deGarmo P. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke 21 (1990) 572-576
10. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
11. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., and Stampfer M.J. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 25 (1994) 1924-1930
12. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., and Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346 (1995) 1395-1398
13. Boushey C.J., Beresford S.A.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
14. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
15. Markus H.S., Nadira A., Swaminathan R., Sankaralingam A., Molloy J., and Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28 (1997) 1739-1743
16. Reuner K.H., Ruf A., Kaps M., Druschky K.F., and Patscheke H. The mutation C677T in the methylenetetrahydrofolate reductase gene and stroke. Thromb Haemost 79 (1998) 450-451
17. Harmon D.L., Doyle R.M., Meleady R., et al. Genetic analysis of the thermolabile variant of 5,10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler Thromb Vasc Biol 99 (1999) 208-211
18. Morita H., Kurihara H., Tsubaki S., et al. Methylene tetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 18 (1998) 1465-1469
19. Markus H.S., Ruigrok Y., Ali N., and Powell J.F. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 29 (1998) 1908-1911
20. Lee T.H., Hsu W.C., Chen C.J., and Chen S.T. Etiologic study of young ischemic stroke in Taiwan. Stroke 33 (2002) 1950-1955
21. Adams Jr. H.P., Kappelle L.J., Biller J., et al. Ischemic stroke in young adults: experience in 329 patients enrolled in the Iowa Registry of Stroke in Young Adults. Arch Neurol 52 (1995) 491-495
22. Qureshi A.I., Safdar K., Patel M., Janssen R.S., and Frankel M.R. Stroke in young black patients: risk factors, subtypes, and prognosis. Stroke 26 (1995) 1995-1998
23. Hassan A., Gormley K., O'Sullivan M., et al. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
24. Timothy D., Wayne H., Jianfeng X., et al. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke 36 (2005) 1848-1853
25. Hou L., Osei-Hyiaman D., Yu H., et al. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurol 56 (2001) 490-496
26. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., and Wicken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2 (1996) 41-45
27. Ichihara S., Yamada Y., Fujimura T., Nakashima N., and Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 81 (1998) 83-86
28. Hooper W.C., Lally C., Austin H., et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116 (1999) 880-886
29. Komitopoulou A., Platokouki H., Kapsimali Z., Pergantou H., Adamtziki E., and Aronis S. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis 22 (2006) 13-20
30. Welch G.N., and Lascalzo J. Homocysteine and atherothrombosis. N Eng J Med 338 (1998) 1042-1050